These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

800 related articles for article (PubMed ID: 25278572)

  • 41. Brain inositol is a novel stimulator for promoting Cryptococcus penetration of the blood-brain barrier.
    Liu TB; Kim JC; Wang Y; Toffaletti DL; Eugenin E; Perfect JR; Kim KJ; Xue C
    PLoS Pathog; 2013; 9(4):e1003247. PubMed ID: 23592982
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Olfactory nerve--a novel invasion route of Neisseria meningitidis to reach the meninges.
    Sjölinder H; Jonsson AB
    PLoS One; 2010 Nov; 5(11):e14034. PubMed ID: 21124975
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Molecular and cellular mechanisms for microbial entry into the CNS.
    Zhang JR; Tuomanen E
    J Neurovirol; 1999 Dec; 5(6):591-603. PubMed ID: 10602400
    [TBL] [Abstract][Full Text] [Related]  

  • 44.
    Jitprasutwit N; Rungruengkitkun A; Lohitthai S; Reamtong O; Indrawattana N; Sookrung N; Sricharunrat T; Sukphopetch P; Chatratita N; Pumirat P
    Microbiol Spectr; 2023 Aug; 11(4):e0132023. PubMed ID: 37409935
    [TBL] [Abstract][Full Text] [Related]  

  • 45. The adaptive immune system in diseases of the central nervous system.
    Wraith DC; Nicholson LB
    J Clin Invest; 2012 Apr; 122(4):1172-9. PubMed ID: 22466659
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Improving brain drug targeting through exploitation of the nose-to-brain route: a physiological and pharmacokinetic perspective.
    Badhan RK; Kaur M; Lungare S; Obuobi S
    Curr Drug Deliv; 2014; 11(4):458-71. PubMed ID: 24655046
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Structural pathways for macromolecular and cellular transport across the blood-brain barrier during inflammatory conditions. Review.
    Lossinsky AS; Shivers RR
    Histol Histopathol; 2004 Apr; 19(2):535-64. PubMed ID: 15024715
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Concepts and mechanisms: crossing host barriers.
    Doran KS; Banerjee A; Disson O; Lecuit M
    Cold Spring Harb Perspect Med; 2013 Jul; 3(7):. PubMed ID: 23818514
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Delivery of insulin-like growth factor-I to the rat brain and spinal cord along olfactory and trigeminal pathways following intranasal administration.
    Thorne RG; Pronk GJ; Padmanabhan V; Frey WH
    Neuroscience; 2004; 127(2):481-96. PubMed ID: 15262337
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Burkholderia pseudomallei-loaded cells act as a Trojan horse to invade the brain during endotoxemia.
    Hsueh PT; Lin HH; Liu CL; Ni WF; Chen YL; Chen YS
    Sci Rep; 2018 Sep; 8(1):13632. PubMed ID: 30206252
    [TBL] [Abstract][Full Text] [Related]  

  • 51. The blood cerebrospinal fluid barrier orchestrates immunosurveillance, immunoprotection, and immunopathology in the central nervous system.
    Ayub M; Jin HK; Bae JS
    BMB Rep; 2021 Apr; 54(4):196-202. PubMed ID: 33298242
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Novel insights into the glia limitans of the olfactory nervous system.
    Nazareth L; Chen M; Shelper T; Shah M; Tello Velasquez J; Walkden H; Beacham I; Batzloff M; Rayfield A; Todorovic M; Beagley KW; St John JA; Ekberg JAK
    J Comp Neurol; 2019 May; 527(7):1228-1244. PubMed ID: 30592044
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Different Involvement of Vimentin during Invasion by
    Banovic F; Schulze S; Abu Mraheil M; Hain T; Chakraborty T; Orian-Rousseau V; Moroniak S; Weiss C; Ishikawa H; Schroten H; Adam R; Schwerk C
    Int J Mol Sci; 2022 Oct; 23(21):. PubMed ID: 36361697
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Immune-related GTPase Irgm1 exacerbates experimental auto-immune encephalomyelitis by promoting the disruption of blood-brain barrier and blood-cerebrospinal fluid barrier.
    Wang C; Wang C; Dong H; Wu XM; Wang C; Xia F; Li G; Jia X; He S; Jiang X; Li H; Xu H
    Mol Immunol; 2013 Jan; 53(1-2):43-51. PubMed ID: 22796503
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Immune cell entry to central nervous system--current understanding and prospective therapeutic targets.
    Prendergast CT; Anderton SM
    Endocr Metab Immune Disord Drug Targets; 2009 Dec; 9(4):315-27. PubMed ID: 20028334
    [TBL] [Abstract][Full Text] [Related]  

  • 56.
    Nazareth L; Walkden H; Chacko A; Delbaz A; Shelper T; Armitage CW; Reshamwala R; Trim LK; St John JA; Beagley KW; Ekberg JAK
    Front Cell Infect Microbiol; 2020; 10():607779. PubMed ID: 33489937
    [No Abstract]   [Full Text] [Related]  

  • 57. Virulence Factors of Meningitis-Causing Bacteria: Enabling Brain Entry across the Blood-Brain Barrier.
    Herold R; Schroten H; Schwerk C
    Int J Mol Sci; 2019 Oct; 20(21):. PubMed ID: 31671896
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Molecular mechanisms of cryptococcal meningitis.
    Liu TB; Perlin DS; Xue C
    Virulence; 2012; 3(2):173-81. PubMed ID: 22460646
    [TBL] [Abstract][Full Text] [Related]  

  • 59. CNS infection and immune privilege.
    Forrester JV; McMenamin PG; Dando SJ
    Nat Rev Neurosci; 2018 Nov; 19(11):655-671. PubMed ID: 30310148
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Intranasal Drug Delivery: A Non-Invasive Approach for the Better Delivery of Neurotherapeutics.
    Kumar H; Mishra G; Sharma AK; Gothwal A; Kesharwani P; Gupta U
    Pharm Nanotechnol; 2017; 5(3):203-214. PubMed ID: 28521670
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 40.